CIH Practitioner Mentorship in Translational Clinical Research

CIH 转化临床研究从业者指导

基本信息

  • 批准号:
    10273070
  • 负责人:
  • 金额:
    $ 9.51万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-21 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

Project Summary The parent study, Xanthohumol Microbiome and Signature (XMaS), is a RO1-funded, multiple principal investigator-led, FDA-approved clinical trial that completed its Phase 1 clinical operation earlier this year. The Phase 1 trial aimed to determine the safety and tolerability of a natural product made from xanthohumol (XN), a compound found in Humulus lupulus (hops), in healthy adults. In addition to assessing safety, collaborators on the trial from Oregon State University will also generate data on XN metabolites and its effects on biomarkers of inflammation and gut integrity, and collaborators at the Pacific Northwest National Laboratory will determine the effects of XN on the microbiota through sequencing and metabolomics profiling. Collectively, these data will be used as comparison data for the Phase 2 clinical trial in Crohn’s Disease, which began recruitment on September 16th, 2020. The additional support of a second-year administrative supplement for Dr. Langley will allow for continued training opportunity for a post-doctoral, early-career Complementary and Integrative Health (CIH) clinician by: 1. Building upon experience in the conduct of clinical trials through participation in the operational aspects of an active clinical trial while under the leadership and mentorship of an experienced team of researchers; 2. Gaining exposure and instruction on the translational scientific methods and techniques used in the collaborative laboratories of the multi-PI team; 3. Encouraging skill development in technical writing, presentation, publication, and statistical analysis; and 4. Developing skills in biostatistics, epidemiology, and clinical trial methodology through didactic coursework. Trial participation will be initiated by training the candidate in clinical screenings and other visits, including: collection of survey data and biologic specimens, and adverse event reporting, as outlined in the trial protocol. The candidate will also gain exposure to specific assays included in the trial, such as microbiota sequencing and metabolomic profiling, through hands-on experience with rotations in each collaborative lab. Finally, skills development in biostatistics, presentation, and future publication will be conducted by finalizing the scoping review currently in development, biostatistics and epidemiology coursework, continuing manuscript development, and performing secondary data analysis under the mentorship of our resident biostatistician. With the successful completion of his initial year of training, a second year of support for Dr. Langley will provide valuable experience as he becomes more competitive for future training awards in clinical and translational research.
项目摘要 母研究Xanthohumol Microbiome and Signature(XMaS)是一项由RO 1资助的多项主要研究。 FDA批准的临床试验,今年早些时候完成了第一阶段的临床操作。的 第一阶段试验旨在确定由黄腐酚(XN)制成的天然产品的安全性和耐受性, 在健康的成年人身上发现的啤酒花中的一种化合物。除了评估安全性外,合作者还 来自俄勒冈州州立大学的试验也将产生关于XN代谢物及其对生物标志物的影响的数据, 炎症和肠道完整性,太平洋西北国家实验室的合作者将确定 通过测序和代谢组学分析XN对微生物群的影响。这些数据将被 用作克罗恩病2期临床试验的比较数据,该试验于9月开始招募 2020年16日。兰利博士第二年行政补助的额外支持将允许 继续培训机会,博士后,早期职业补充和综合健康(CIH) 临床医生:1.通过参与操作性临床试验, 积极的临床试验的各个方面,同时在经验丰富的团队的领导和指导下, 研究人员; 2。获得在翻译中使用的科学方法和技术的曝光和指导, 多PI团队的协作实验室; 3.鼓励技术写作技能的发展, 介绍、出版和统计分析; 4.培养生物统计学、流行病学和 临床试验方法通过教学课程。将通过培训候选人启动试验参与 在临床筛查和其他访问中,包括:收集调查数据和生物标本,以及不良反应 事件报告,如试验方案所述。候选人还将接触特定的检测,包括 在试验中,例如微生物群测序和代谢组学分析,通过轮换的实践经验, 在每个合作实验室。最后,将在生物统计,演示和未来的出版物的技能发展 通过完成目前正在制定的范围界定审查、生物统计学和流行病学课程作业, 继续手稿开发,并在我们的指导下进行二级数据分析 常驻生物统计学家随着他第一年培训的顺利完成,第二年的支持, 博士兰利将提供宝贵的经验,因为他成为更有竞争力的未来培训奖项,在临床 和翻译研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ryan D Bradley其他文献

Ryan D Bradley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ryan D Bradley', 18)}}的其他基金

Mentorship in Clinical Complementary and Integrative Health Research
临床补充和综合健康研究的指导
  • 批准号:
    10670137
  • 财政年份:
    2021
  • 资助金额:
    $ 9.51万
  • 项目类别:
Mentorship in Clinical Complementary and Integrative Health Research
临床补充和综合健康研究的指导
  • 批准号:
    10458680
  • 财政年份:
    2021
  • 资助金额:
    $ 9.51万
  • 项目类别:
Mentorship in Clinical Complementary and Integrative Health Research
临床补充和综合健康研究的指导
  • 批准号:
    10283872
  • 财政年份:
    2021
  • 资助金额:
    $ 9.51万
  • 项目类别:
Discovery and Biological Signatures of Microbiome-Derived Xanthohumol Metabolites and their Role in Ameliorating Inflammatory Bowel Disease
微生物组衍生的黄腐酚代谢物的发现和生物学特征及其在改善炎症性肠病中的作用
  • 批准号:
    9789841
  • 财政年份:
    2018
  • 资助金额:
    $ 9.51万
  • 项目类别:
Discovery and Biological Signatures of Microbiome-Derived Xanthohumol Metabolites and their Role in Ameliorating Inflammatory Bowel Disease
微生物组衍生的黄腐酚代谢物的发现和生物学特征及其在改善炎症性肠病中的作用
  • 批准号:
    10237375
  • 财政年份:
    2018
  • 资助金额:
    $ 9.51万
  • 项目类别:
CIH Practitioner Mentorship in Translational Clinical Research
CIH 转化临床研究从业者指导
  • 批准号:
    10027107
  • 财政年份:
    2018
  • 资助金额:
    $ 9.51万
  • 项目类别:
Discovery and Biological Signatures of Microbiome-Derived Xanthohumol Metabolites and their Role in Ameliorating Inflammatory Bowel Disease
微生物组衍生的黄腐酚代谢物的发现和生物学特征及其在改善炎症性肠病中的作用
  • 批准号:
    10472280
  • 财政年份:
    2018
  • 资助金额:
    $ 9.51万
  • 项目类别:
Building Research across Interdisciplinary Gaps (BRIDG) R90 Training Program
跨学科差距建设研究 (BRIDG) R90 培训计划
  • 批准号:
    10622503
  • 财政年份:
    2015
  • 资助金额:
    $ 9.51万
  • 项目类别:
Building Research across Interdisciplinary Gaps (BRIDG) R90 Training Program
跨学科差距建设研究 (BRIDG) R90 培训计划
  • 批准号:
    10427173
  • 财政年份:
    2015
  • 资助金额:
    $ 9.51万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9.51万
  • 项目类别:
    Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 9.51万
  • 项目类别:
    Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 9.51万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 9.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 9.51万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 9.51万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 9.51万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 9.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 9.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 9.51万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了